Clinical Trials

The way the pharma industry has traditionally handled clinical trials does not make participation easy.

On the 70th anniversary of death Henrietta Lacks, we examine her contributions to science and what they mean for modern research.

AI is expanding into medicine. Are the world’s regulators ready?

Aging digital systems limit the potential of decentralized trials. It's time to rethink the technologies driving them.

How the Drugs for Neglected Diseases Initiative and the Malaysian government partnered to tackle hep C with an affordable, effective cure.

How can we maximize the potential and production of potentially life-saving therapies?

When it comes to conducting clinical trials in emerging geographies, there are four key challenges to consider.

How can we ease the process of taking ATMPs to clinical trials? Two experts lay out the key considerations.

Can a new malaria vaccine hold the key to reliable, durable protection?

The lack of female representation in clinical trials impairs the very foundation that the development of safe and effective medicines is built upon.